Presence may suggest Dr. Martin Lerner's theory of aborted EBV infection.
Dr Martin Lerner's proposal was that in ME/CFS, there can be chronic active herpesvirus infections, but he believed these are not like regular chronic infections, but are abortive infections. Abortive infections can be ongoing chronic infections, but which rather unusually do not produce any new viral particles.
Hi all,
I know that the Lerner and Beqaj theory of abortive EBV infection is widely promoted in this forum. However, while Lerner and Beqaj have published an ‘hypothesis paper’ on this theory (Virus Adaptation and Treatment 2012:4 85–91), as yet, it doesn’t appear to be supported by any solid science.
It is important to point out that there is nothing wrong with Lerner and Beqaj publishing "hypothesis papers". Such papers are important for stimulating new ideas and new research. But hypotheses should not be conflated beyond what they seek to provide:- An interesting hypothesis that is worthy of scientific investigation. To date, the proposals made in their 'hypothesis paper' havent been confirmed clinically. Thus, such hypothesis papers shouldn’t be mistaken for actual robust scientific evidence.
But I think it is worth discussing some of the key ideas and whether they may be relevant to CFS.
Firstly, I think some of the confusion with the abortive EBV infection hypothesis is centered on how viral serology is clinically interpreted. In most instances, the presence of a particular antibody in the serum of an individual is simply a historical record of an invasion by foreign pathogen (there are some notable exceptions such as the presence of autoantibodies). From the time an EBV virion infects a cell to the time the infected cell bursts open to release 10,000s of infectious viral particles, EBV will produce nearly 100 different proteins. Some proteins are produced early during the infection (eg. Early Antigen, EA), some are produced later (eg. EBNAs), and some are produced even later and are required for viral replication (eg. EBV dUTPase, and EBV DNA polymerase). Because serology reflects the historical record of infection, EBV serology is simply the
sum total of all the anti-EBV antibodies that have been produced from the first EBV infection, to Infectious Mononucleosis (IM) and finally during recovery from IM.
Some of the EBV serology profiles and their interpretation is pasted in the table below (from J of Virol, 12:1-31). I have highlighted the serological pattern of
@.jm. Note that table indicates either i) acute infection or ii) non-specificity. My suggestions earlier also included a 3rd possibility that might involve the expansion of a lymphocyte clone. The recommendation in the table is "further testing required' which I agree is very important in any cases with anomolous EBV serological profiles.
ANYWAY, getting back to the hypothesis of Lerner and Beqaj. Essentially it fails to recognize that the presence of a particular antibody cannot be used to diagnose specific
types of infection such as latent infection, abortive replication or even sporatic/partial EBV reactivation.
Using their specific example, they propose:
“A small group of six patients in the group-A EBV subset of CFS, additionally, had repetitive elevated-serum titers of antibody to the early lytic replication-encoded proteins, EBV dUTPase, and EBV DNA polymerase. The
presence of these serum antibodies to EBV dUTPase and EBV DNA polymerase
indicated EBV abortive lytic replication in these 6 CFS patients.” (Virus Adaptation and Treatment 2012:4 85–91)(my bolding)
Unfortunately, such a conclusion cannot be made. “The
presence of serum antibodies to EBV dUTPase, and EBV DNA polymerase..” simply means that sometime in the past, the individual has been infected with EBV and that the virus has produced dUTPase and DNA polymerase in order to replicate (my bold). The virus may have produced dUTPase and DNA polymerase during:
- a primary infection,
- abortive replication or
- EBV reactivation.
The mere
presence of antibodies to dUTPase and DNA polymerase doesnt allow these 3 very different scenarios to be distinguished. While the presence of IgG antibodies to EBV dUTPase and DNA polymerase would indicate a past infection, it doesn’t allow the differential diagnosis of which type of infection, when it occurred or even whether it might be ongoing.
There is also another common misunderstanding in terms of EBV serology. Antibodies against foreign pathogens can persist for decades in the circulation. So the presence of antibodies to EBV
replicative proteins may have nothing to do with abortive replication. Their presence in the circulation may simply represent an historical record of viral infection and replication that occurred many years beforehand.
Another common misconception is the clinical significance of EBV antibody titres. Some CFS practitioners contend that high EBV antibody titres indicate ongoing active infections. However, the clinical reality is that EBV antibody titres dont allow differential diagnosis of CFS and certainly dont allow identification of abortive replication. The simple reason is that each person's immune system reacts very differently to foreign antigens and so antibody titre doesnt provide a reliable diagnostic tool for identifying abortive replication. This critical point has been made in several studies investigating EBV antibody titres and CFS (J. Med. Virol. 82:1684-1688)(Journal of Molecular Diagnostics, Vol. 3, No. 1).
To illustrate this point, a person with a past EBV infection who is perfectly healthy may have a high IgG antibody titre to a particular EBV protein while a person diagnosed with post-EBV CFS may have a low IgG antibody titre to the same protein. The exact opposite scenario can also occur in a different individual. Thus, in each individual, the diagnostic conclusion would be simply that each person has had a past EBV infection. While serology is very helpful in accurately distinguishing between i) EBV naive, ii) acute EBV infection and iii) EBV past infection, it doesnt provide a reliable diagnostic indicator of latent, abortive or even reactivated infection (NEJM, 343:7, 481).
For these reasons,
“repetitive elevated-serum titers of antibody to the early lytic replication-encoded proteins, EBV dUTPase, and EBV DNA polymerase” as proposed by Lerner and Beqaj would not reflect abortive replication in CFS. Again, it simply reflects an historical record of a past infection where viral replication occurred.
Abortive infections can be ongoing chronic infections......
This is not really true. Chronic Activated EBV infections are a distinct diagnostic category and entirely different to EBV-related CFS and are not considered Abortive Infections. But, it is true that in Chronic Activated EBV infections, viral titres may actually be important diagnostically. For example, high EBV antibody titres have been identified in Chronic Active EBV infection. In addition, high EBV antibody titres can be considered 'red flags' for some EBV-mediated tumors including lymphomas and nasopharangeal carcinomas.
However, these conditions have different diagnostic criteria to CFS and are entirely different diseases. For example, Chronic Active EBV infections are ii) a serious medical condition that requires immediate medical intervention, ii) characterized by significant morbidity and mortality and iii) a distinct and recognizably different pathology to CFS (American Journal of Hematology 80:64–69). The term 'Chronic Active EBV infection' is often mistakenly used to describe some types of CFS that arise from a EBV infection. However, such medical terminology is misleading.
The clinical features of Chronic Active EBV infection include i) ongoing non-resolving IM symptoms (the diagnostic features of CFS and IM are different), ii) unusual patterns of EBV antibodies, iii) high anti-EBV antibody titres (high antibody titres are not considered diagnostic feature of CFS), and iv) high viral load in the
serum/
plasma (CFS patients dont generally have high viral loads in
serum or
plasma). Again, patients with Chronic Active EBV infections are incredibly sick, have high mortality rates and the disease is clinically distinct from CFS. The 2 conditions should not be confused.
One last caveat! We shouldnt completely exclude the possibility that
some EBV serology profiles may have diagnostic potential in at least some
subsets of CFS patients. For example, it appears that EBNA IgG antibodies are not generated in at least some CFS patients (cant find the ref for this, but i'll try and dig it up). It may be that failure to generate EBNA IgGs allows ongoing latent EBV infections that that predispose to CFS.
Question: Are many EBV-related CFS patients here EBV VCA-IgG-positive but EBNA-negative?
Rodger